EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Cytek Biosciences, Inc. (CTKB) EBITDA Margin data is not available.
| Income Statement Financials | |
$41.46M |
|
$-11.40M |
|
$21.30M |
|
$20.16M |
|
$56.43M |
|
$-14.97M |
|
$3.71M |
|
$-11.27M |
|
$-11.27M |
|
$-11.40M |
|
$-11.40M |
|
$-11.40M |
|
$-11.40M |
|
$-14.97M |
|
$-12.09M |
|
128.34M |
|
128.34M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$380.50M |
|
$17.83M |
|
$102.09M |
|
$482.60M |
|
$67.69M |
|
$0.92M |
|
$35.28M |
|
$102.97M |
|
$379.62M |
|
$343.51M |
|
$379.62M |
|
127.60M |
|
| Cash Flow Statement Financials | |
$-0.12M |
|
$9.45M |
|
$-11.54M |
|
$98.75M |
|
$95.30M |
|
$-3.45M |
|
$6.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.62 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
48.62% |
|
-36.12% |
|
-36.12% |
|
|
EBITDA Margin |
-- |
-27.18% |
|
-27.50% |
|
$-0.94M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.47 |
|
0.75 |
|
119.46 |
|
-3.00% |
|
-3.32% |
|
-2.36% |
|
-3.00% |
|
$2.98 |
|
$-0.01 |
|
$-0.00 |
|